上腺素阻断关键细胞循环基因,并表现出抗纤维素和血管缩作用在眼外科手术中
Kai Xin Thong1, Petru Andriesei1, Jinyuan Luo1
1Faculty of Life Sciences & Medicine, King's College London, London, SE1 7EH, UK.
Experimental eye research
|July 10, 2023
概括
上腺素通过降低纤维细胞收缩性和阻断细胞循环基因来表现出抗纤维素作用,这使得它成为预防瘤痕手术的安全有效选择.
科学领域:
- 眼科医生 眼科 眼科
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 玻璃眼瘤手术的目的是降低眼内压力.
- 纤维化是导致青光眼手术失败的主要原因.
- 上腺素是一种同情药物,已知用于眼部.
研究的目的:
- 为了研究上腺素在眼外科手术中的抗纤维化潜力.
- 评估上腺素对纤维细胞活动和基因表达的影响.
主要方法:
- 用纤维细胞填充的原体收缩试验来测量收缩性.
- 人类的纤维细胞被用上腺素治疗,并通过RNA测序进行分析.
- 上腺素在绿眼的手术中被分泌到下结合膜 (trabeculectomy,microshunt,管道).
主要成果:
- 上腺素显著降低了纤维细胞收缩性,以剂量依赖的方式.
- RNA测序揭示了上腺素对细胞周期和与线粒分裂相关的基因的影响.
- 在玻璃眼外科手术中注射副联上腺素没有显示任何不良影响.
结论:
- 上腺素通过抑制纤维细胞收缩性和调节细胞循环基因,表现出显著的抗纤维素特性.
- 上腺素是一种安全的,具有成本效益的药物,用于在格洛科马形成斑块的手术中进行子结膜注射.
- 这项研究建议使用上腺素来提高青光眼手术的结果.
相关概念视频
Open Angle Glaucoma: Treatment
481
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
481
Angle Closure Glaucoma: Treatment
574
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
574
Adrenergic Agonists: Therapeutic Uses
858
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
858
Glaucoma: Overview
623
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
623
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
893
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
893
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
889
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
889


